Literature DB >> 17328961

Temperament and character dimensions in patients with social phobia: patterns of change following treatments?

Ewa Mörtberg1, Susanne Bejerot, Anna Aberg Wistedt.   

Abstract

The aim of this study was to examine Temperament and Character Inventory (TCI) profiles in patients with social phobia (DSM-IV) and to outline patterns of change following intensive group cognitive therapy (IGCT), individual cognitive therapy (ICT) and treatment as usual (TAU). One hundred patients recruited by advertisements in local papers were randomized to IGCT, ICT and TAU. Patients (n=59) who completed diagnostic evaluation and TCI assessments at baseline and 1-year follow-up were examined in this study. Patients differed from healthy controls in novelty seeking (NS), harm avoidance (HA), self-directedness (SD), cooperativeness (C), and self-transcendence (ST). Treatments overall were associated with decrease in HA, while increase in SD was observed after psychotherapy only. Reduced social anxiety was correlated with decrease in HA and increase in SD. High HA at baseline was related to poor treatment outcome in all treatments. To conclude, patients with social phobia show a temperamental vulnerability for developing anxiety and character traits associated with personality disorders. Successful treatment is related to decrease in HA and increase in SD. High HA at baseline may suggest a need for extensive treatment in order to achieve remission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328961     DOI: 10.1016/j.psychres.2006.10.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  Psychological interventions for antisocial personality disorder.

Authors:  Simon Gibbon; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

2.  Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians.

Authors:  Nathalie Besnier; Catherine Cassé-Perrot; Elisabeth Jouve; Nhan Nguyen; Christophe Lançon; Bruno Falissard; Olivier Blin
Journal:  Psychopharmacology (Berl)       Date:  2009-10-14       Impact factor: 4.530

3.  Psychological interventions for antisocial personality disorder.

Authors:  Simon Gibbon; Najat R Khalifa; Natalie H-Y Cheung; Birgit A Völlm; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03

4.  Personality change following internet-based cognitive behavior therapy for severe health anxiety.

Authors:  Erik Hedman; Gerhard Andersson; Nils Lindefors; Petter Gustavsson; Mats Lekander; Christian Rück; Erik Andersson; Brjánn Ljótsson
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

5.  Do Patient Characteristics Predict Outcome of Psychodynamic Psychotherapy for Social Anxiety Disorder?

Authors:  Jörg Wiltink; Jürgen Hoyer; Manfred E Beutel; Christian Ruckes; Stephan Herpertz; Peter Joraschky; Susan Koranyi; Matthias Michal; Björn Nolting; Karin Pöhlmann; Simone Salzer; Bernhard Strauss; Eric Leibing; Falk Leichsenring
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

6.  Higher- and lower-order personality traits and cluster subtypes in social anxiety disorder.

Authors:  Mădălina Elena Costache; Andreas Frick; Kristoffer Månsson; Jonas Engman; Vanda Faria; Olof Hjorth; Johanna M Hoppe; Malin Gingnell; Örjan Frans; Johannes Björkstrand; Jörgen Rosén; Iman Alaie; Fredrik Åhs; Clas Linnman; Kurt Wahlstedt; Maria Tillfors; Ina Marteinsdottir; Mats Fredrikson; Tomas Furmark
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

7.  Effects of temperament and character profiles on state and trait depression and anxiety: a prospective study of a Japanese youth population.

Authors:  Xi Lu; Zi Chen; Xiaoyi Cui; Masayo Uji; Wataru Miyazaki; Masako Oda; Toshiaki Nagata; Toshinori Kitamura; Takahiko Katoh
Journal:  Depress Res Treat       Date:  2012-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.